Skip to main content

Table 3 Characteristics of the subjects divided according to CFS duration

From: The increase of alpha-melanocyte-stimulating hormone in the plasma of chronic fatigue syndrome patients

 

6-60 months

61-120 months

Age

33.6 ± 1.7 (n = 25)

36.9 ± 1.5 (n = 30)

Male

9

15

Female

16

15

BMI (kg/m2)

21.4 ± 0.63 (n = 25)

21.1 ± 0.59 (n = 30)

α-MSH (pg/mL)

20.8 ± 1.2 (n = 25)

15.6 ± 1.4 (n = 30)*

ACTH (pg/mL)

29.3 ± 3.7 (n = 18)

23.44 ± 3.3 (n = 25)

Cortisol (mg/dL)

16.4 ± 1.6 (n = 18)

12.9 ± 1.2 (n = 25)

DHEA-S (mg/dL)

163.4 ± 16.5 (n = 18)

167.88 ± 15.7 (n = 25)

  1. Results are given as mean ± SEM.
  2. *p < 0.05 between 6-60-month group and 61-120-month group (Tukey's test).
Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us